“Predictive Significance of Interleukins 17A and 33 in Risk of Relapsing–Remitting Multiple Sclerosis”. Baghdad Science Journal, vol. 19, no. 6, Dec. 2022, p. 1191, https://doi.org/10.21123/bsj.2022.6431.